We were featured in Livewire alongside Wilson Asset Management and Plato Investment Management, discussing long-term investment strategies and identifying future market leaders. Our global equities fund recently demonstrated our adaptive approach to portfolio management when rapid advances in AI coding tools shifted our outlook on traditional software names. As Arms Rosenberg explained:
The best thing to do when things are changing quickly is to sit still and just think with a blank sheet of paper with all the information I have today. Try not to be anchored to decisions that you've made in the past.
Our current global equities positions include Chugai Pharmaceutical, a Japanese company developing oral GLP-1 drugs that remains largely unknown outside Japan, and UniCredit, a European bank experiencing sustained re-rating with 20 consecutive quarters of earnings upgrades. Rosenberg also emphasised the importance of diversification in portfolio management, noting that concentrated portfolios carry hidden factor and sector risks. For long-term opportunities, we highlighted Artrya, an ASX-listed company using AI to diagnose coronary artery disease, as a ten-year investment thesis. This discussion showcased our approach to disciplined equity research and portfolio construction in navigating rapidly changing markets. To read the article, click the link below.